Modus Therapeutics Holding AB
MODTX
Rank in Stocks
#32426
Modus Therapeutics Holding AB (publ), a biotechnology company, develops a... Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. It develops Sevuparin, a lipopolysaccharide in Phase IIa trial to treat patients with sepsis, septic shock, anemia associated with chronic kidney disease, endotoxemia, severe malaria, and other diseases involving severe systemic inflammation. Modus Therapeutics Holding AB (publ) was founded in 2011 and is headquartered in Stockholm, Sweden.
Share Price
$0.01734444
Last synced: 2026-11-09
Market Cap
$1.58M
Change (1 day)
7.23%
Change (1 year)
-55.43%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Modus Therapeutics Holding AB (MODTX)
Category
Healthcare
EPS for Modus Therapeutics Holding AB (MODTX)
EPS as of June 2026 TTM: $-0.02
According to Modus Therapeutics Holding AB's latest financial reports, its current EPS (TTM) is $-0.02. At the end of 2025 the company had an EPS of $-0.03, an increase over its 2024 EPS of $-0.04.
EPS history for Modus Therapeutics Holding AB from 2018 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.02 | -39.33% |
| 2025 | $-0.03 | -16.67% |
| 2024 | $-0.04 | -61.04% |
| 2023 | $-0.10 | -8.42% |
| 2022 | $-0.11 | -40.76% |
| 2021 | $-0.18 | 311.83% |
| 2020 | $-0.04 | -84.57% |
| 2019 | $-0.29 | -15.81% |
| 2018 | $-0.34 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -86,143.96% |
US
|
|
| $-7.07 | 38,746.15% |
US
|
|
| $-5.29 | 28,965.93% |
AU
|
|
| $12.88 | -70,869.78% |
BE
|
|
| $21.56 | -118,561.54% |
NL
|
Questions about Modus Therapeutics Holding AB's earnings per share (EPS)
What is Modus Therapeutics Holding AB's earnings per share (EPS)?
Modus Therapeutics Holding AB's earnings per share (EPS) over the last twelve months is $-0.02, as of Jun 2026.
What was Modus Therapeutics Holding AB's earnings per share (EPS) in 2025?
In 2025, Modus Therapeutics Holding AB's earnings per share (EPS) was $-0.03, compared with $-0.04 in 2024.
How has Modus Therapeutics Holding AB's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Modus Therapeutics Holding AB's earnings per share (EPS) was highest in 2025 ($-0.03) and lowest in 2021 ($-0.18).
How does Modus Therapeutics Holding AB's earnings per share (EPS) compare with similar companies?
Modus Therapeutics Holding AB's earnings per share (EPS) ($-0.02) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.